XML 69 R65.htm IDEA: XBRL DOCUMENT v3.20.2
Significant Accounting Policies and Judgments - Adjustments for Change in Accounting Policy (Details) - CAD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jul. 01, 2019
Statement of financial position [abstract]      
Biological assets $ 35,435 $ 50,567  
Inventory 121,827 111,321  
Deferred tax liability 3,946 90,970  
Deficit (3,592,787) (286,311) $ (283,639)
Statement of profit or loss and other comprehensive income [abstract]      
Cost of sales 277,234 123,778  
Gross profit before fair value adjustments 1,672 121,758  
Changes in fair value of inventory sold 91,825 71,821  
Unrealized gain on changes in fair value of biological assets (56,614) (92,503)  
Gross profit (loss) (33,539) 142,440  
General and administration 205,276 159,069  
Deferred tax (recovery) expense (78,303) (23,909)  
Loss from continued operations $ (3,300,493) (300,740)  
Net loss attributable to Aurora shareholders   $ (293,509)  
Basic and diluted earnings (loss) per share $ (33.94) $ (3.66)  
Statement of cash flows [abstract]      
Unrealized gain on changes in fair value of biological assets $ (56,614) $ (92,503)  
Changes in fair value included in inventory sold 91,825 71,821  
Deferred tax expense (recovery) (78,303) (23,909)  
Changes in non-cash working capital 7,643 (37,285)  
Net cash used in operating activities $ (337,952) (192,245)  
As previously reported      
Statement of financial position [abstract]      
Biological assets   51,836  
Inventory   113,641  
Deferred tax liability   91,886  
Deficit   (283,639)  
Statement of profit or loss and other comprehensive income [abstract]      
Cost of sales   112,526  
Gross profit before fair value adjustments   135,413  
Changes in fair value of inventory sold   72,129  
Unrealized gain on changes in fair value of biological assets   (96,531)  
Gross profit (loss)   159,815  
General and administration   172,365  
Deferred tax (recovery) expense   (23,257)  
Loss from continued operations   (297,924)  
Net loss attributable to Aurora shareholders   $ (290,837)  
Basic and diluted earnings (loss) per share   $ (3.63)  
Statement of cash flows [abstract]      
Unrealized gain on changes in fair value of biological assets   $ (96,531)  
Changes in fair value included in inventory sold   72,129  
Deferred tax expense (recovery)   (23,257)  
Changes in non-cash working capital   (37,952)  
Net cash used in operating activities   (192,245)  
Adjustments | Change in accounting policy for inventory costing of by-products and allocation of operational staff salaries, inventory adjustments      
Statement of financial position [abstract]      
Biological assets   (1,269)  
Inventory   (2,320)  
Deferred tax liability   (916)  
Deficit   (2,672)  
Statement of profit or loss and other comprehensive income [abstract]      
Cost of sales   11,252  
Gross profit before fair value adjustments   (11,252)  
Changes in fair value of inventory sold   (308)  
Unrealized gain on changes in fair value of biological assets   4,028  
Gross profit (loss)   (14,972)  
General and administration   (11,384)  
Deferred tax (recovery) expense   (916)  
Loss from continued operations   (2,672)  
Net loss attributable to Aurora shareholders   $ (2,672)  
Basic and diluted earnings (loss) per share   $ (0.03)  
Statement of cash flows [abstract]      
Unrealized gain on changes in fair value of biological assets   $ 4,028  
Changes in fair value included in inventory sold   (308)  
Deferred tax expense (recovery)   (916)  
Changes in non-cash working capital   (211)  
Net cash used in operating activities   0  
Adjustments | Change in accounting policy for inventory costing of by-products and allocation of operational staff salaries, inventory adjustments | Discontinued operations      
Statement of financial position [abstract]      
Biological assets   0  
Inventory   0  
Deferred tax liability   0  
Deficit   0  
Statement of profit or loss and other comprehensive income [abstract]      
Cost of sales   0  
Gross profit before fair value adjustments   (2,403)  
Changes in fair value of inventory sold   0  
Unrealized gain on changes in fair value of biological assets   0  
Gross profit (loss)   (2,403)  
General and administration   (1,912)  
Deferred tax (recovery) expense   264  
Loss from continued operations   (144)  
Net loss attributable to Aurora shareholders   0  
Statement of cash flows [abstract]      
Unrealized gain on changes in fair value of biological assets   0  
Changes in fair value included in inventory sold   0  
Deferred tax expense (recovery)   264  
Changes in non-cash working capital   878  
Net cash used in operating activities   $ 0